These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21774092)

  • 21. [Peripheral neuroblastic tumors: anatomo pathological classification].
    Peuchmaur M
    Ann Pathol; 2004 Dec; 24(6):556-67. PubMed ID: 15785402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fine-needle aspiration of ganglioneuroma.
    Domanski HA
    Diagn Cytopathol; 2005 Jun; 32(6):363-6. PubMed ID: 15880712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral neuroblastic tumours in eastern Denmark 1972-2002.
    Zimling ZG; Rechnitzer C; Rasmussen M; Petersen BL
    APMIS; 2007 Jan; 115(1):66-74. PubMed ID: 17223852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prognostic factors in neuroblastoma. Usefulness of DNA analysis using flow cytometry on paraffin-embedded material].
    Massara FM; Tonello M; Forni M; Fruttero A; Lantermo R; Pugno F; Cordero di Montezemolo L; Ruà S
    Pediatr Med Chir; 1996; 18(2):141-8. PubMed ID: 8767575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PHOX2B immunolabeling: a novel tool for the diagnosis of undifferentiated neuroblastomas among childhood small round blue-cell tumors.
    Bielle F; Fréneaux P; Jeanne-Pasquier C; Maran-Gonzalez A; Rousseau A; Lamant L; Paris R; Pierron G; Nicolas AV; Sastre-Garau X; Delattre O; Bourdeaut F; Peuchmaur M
    Am J Surg Pathol; 2012 Aug; 36(8):1141-9. PubMed ID: 22790854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathology of neuroblastic tumors.
    Joshi VV; Silverman JF
    Semin Diagn Pathol; 1994 May; 11(2):107-17. PubMed ID: 7809504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maturing neuroblastoma and ganglioneuroblastoma: a study of four cases with long survival.
    McLaughlin JE; Urich H
    J Pathol; 1977 Jan; 121(1):19-26. PubMed ID: 874625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maturation of mass-screened localized adrenal neuroblastoma.
    Iwanaka T; Yamamoto K; Ogawa Y; Arai M; Ito M; Kishimoto H; Hanada R; Imaizumi S
    J Pediatr Surg; 2001 Nov; 36(11):1633-6. PubMed ID: 11685689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinicopathologic features of peripheral neuroblastic tumors].
    Yang BF; Fu LB; He LJ
    Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):305-10. PubMed ID: 24004586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors.
    Maitra A; Yashima K; Rathi A; Timmons CF; Rogers BB; Shay JW; Gazdar AF
    Cancer; 1999 Feb; 85(3):741-9. PubMed ID: 10091748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conventional versus modified morphologic criteria for ganglioneuroblastoma. A review of cases from the Pediatric Oncology Group.
    Joshi VV; Cantor AB; Altshuler G; Cohen LJ; Larkin EW; Shuster JJ; Rao PV; Holbrook CT; Hayes FA; Castleberry RP
    Arch Pathol Lab Med; 1996 Sep; 120(9):859-65. PubMed ID: 9140292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain lipid-binding protein: a marker of differentiation in neuroblastic tumors.
    Retrosi G; Sebire NJ; Bishay M; Kiely EM; Anderson J; De Coppi P; Resca E; Rampling D; Bier N; Mills K; Eaton S; Pierro A
    J Pediatr Surg; 2011 Jun; 46(6):1197-200. PubMed ID: 21683222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An ultrastructural and immunohistochemical evaluation of cytodifferentiation in neuroblastic tumors.
    Hachitanda Y; Tsuneyoshi M; Enjoji M
    Mod Pathol; 1989 Jan; 2(1):13-9. PubMed ID: 2922387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fine needle aspiration cytologic diagnosis of ganglioneuroblastoma.
    Kumar PV
    Acta Cytol; 1987; 31(5):583-6. PubMed ID: 3673462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneity of MYCN amplification in a child with stroma-rich neuroblastoma (ganglioneuroblastoma).
    Lorenzana AN; Zielenska M; Thorner P; Gerrie B; Weitzman S; Squire J
    Pediatr Pathol Lab Med; 1997; 17(6):875-83. PubMed ID: 9353827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification.
    Krams M; Hero B; Berthold F; Parwaresch R; Harms D; Rudolph P
    Cancer; 2002 Feb; 94(3):854-61. PubMed ID: 11857322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tubedown expression correlates with the differentiation status and aggressiveness of neuroblastic tumors.
    Martin DT; Gendron RL; Jarzembowski JA; Perry A; Collins MH; Pushpanathan C; Miskiewicz E; Castle VP; Paradis H
    Clin Cancer Res; 2007 Mar; 13(5):1480-7. PubMed ID: 17332292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fine-needle aspiration (FNA) cytology diagnosis of small round cell tumors: value and limitations.
    Das DK
    Indian J Pathol Microbiol; 2004 Jul; 47(3):309-18. PubMed ID: 16295413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of International Neuroblastoma Pathology Classification in localized resectable peripheral neuroblastic tumors: a histopathologic study of localized neuroblastoma European Study Group 94.01 Trial and Protocol.
    Navarro S; Amann G; Beiske K; Cullinane CJ; d'Amore ES; Gambini C; Mosseri V; De Bernardi B; Michon J; Peuchmaur M;
    J Clin Oncol; 2006 Feb; 24(4):695-9. PubMed ID: 16446343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pediatric neuroblastic tumors: A critical evaluation of cytomorphological features for risk stratification on aspiration cytology.
    Behera G; Chhabra G; Mishra P; Sable M
    Diagn Cytopathol; 2020 May; 48(5):464-474. PubMed ID: 32043835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.